219 related articles for article (PubMed ID: 1858635)
1. Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan.
Hagemeijer F
Am Heart J; 1991 Aug; 122(2):517-22. PubMed ID: 1858635
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
[TBL] [Abstract][Full Text] [Related]
3. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
O'Grady MR; Minors SL; O'Sullivan ML; Horne R
J Vet Intern Med; 2008; 22(4):897-904. PubMed ID: 18537880
[TBL] [Abstract][Full Text] [Related]
4. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
[TBL] [Abstract][Full Text] [Related]
5. [Trends in pharmacological treatment of congestive heart failure].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
[TBL] [Abstract][Full Text] [Related]
6. Fundamental role of angiotensin-converting enzyme inhibitors in the management of congestive heart failure.
Opie LH
Am J Cardiol; 1995 Jun; 75(18):3F-6F. PubMed ID: 7778532
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.
Katz SD; Kubo SH; Jessup M; Brozena S; Troha JM; Wahl J; Cohn JN; Sonnenblick EH; LeJemtel TH
Am Heart J; 1992 Jan; 123(1):95-103. PubMed ID: 1729854
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
Levy E; Levy P
Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacologic treatment of chronic congestive heart failure].
Halawa B
Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
[TBL] [Abstract][Full Text] [Related]
10. Should all patients with congestive heart failure and dilated cardiomyopathy be treated with vasodilators?
Massie BM
Cardiovasc Clin; 1990; 21(1):251-62; discussion 263-4. PubMed ID: 2199051
[TBL] [Abstract][Full Text] [Related]
11. Digoxin and angiotensin converting enzyme inhibitors in chronic heart failure.
Gheorghiade M
Can J Cardiol; 1990 Aug; 6 Suppl C():14C-17C. PubMed ID: 2205342
[TBL] [Abstract][Full Text] [Related]
12. Is there an expanded role for digoxin in patients with heart failure and sinus rhythm? An antagonist viewpoint.
Munger MA; Furniss SM
Ann Pharmacother; 1997; 31(7-8):893-6. PubMed ID: 9220053
[No Abstract] [Full Text] [Related]
13. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
Kromer EP; Elsner D; Riegger GA
J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
[TBL] [Abstract][Full Text] [Related]
14. Current concepts in clinical therapeutics: congestive heart failure.
Klamerus KJ
Clin Pharm; 1986 Jun; 5(6):481-98. PubMed ID: 2872992
[TBL] [Abstract][Full Text] [Related]
15. Medical therapy for chronic congestive heart failure.
Jaeschke R; Guyatt GH
Ann Intern Med; 1989 May; 110(10):758-60. PubMed ID: 2653153
[No Abstract] [Full Text] [Related]
16. [The influence of 3-month treatment with molsidomine on structure, function and some neurohormonal parameters in patients with chronic heart failure treated with digoxin, diuretic and angiotensin converting enzyme inhibitors].
Spring A; Jołda-Mydłowska B; Kosmala W; Witkowska M
Pol Merkur Lekarski; 1998 Jun; 4(24):315-8. PubMed ID: 9771014
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Aronow WS
J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
[TBL] [Abstract][Full Text] [Related]
18. Drug therapy for congestive heart failure. Appropriate choices can prolong life.
Sorrentino MJ
Postgrad Med; 1997 Jan; 101(1):83-6, 89-90, 93-4. PubMed ID: 9008690
[TBL] [Abstract][Full Text] [Related]
19. [Drug treatment of heart insufficiency].
Follath F
Schweiz Med Wochenschr; 1988 Dec; 118(50):1886-91. PubMed ID: 3065935
[TBL] [Abstract][Full Text] [Related]
20. Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
Kao W; Gheorghiade M; Hall V; Goldstein S
Am J Cardiol; 1989 Sep; 64(10):609-13. PubMed ID: 2782251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
